MCRB
Price
$18.99
Change
+$0.11 (+0.58%)
Updated
Aug 28 closing price
Capitalization
166.25M
MTVA
Price
$0.65
Change
+$0.02 (+3.17%)
Updated
Aug 28 closing price
Capitalization
15.66M
Interact to see
Advertisement

MCRB vs MTVA

Header iconMCRB vs MTVA Comparison
Open Charts MCRB vs MTVABanner chart's image
Seres Therapeutics
Price$18.99
Change+$0.11 (+0.58%)
Volume$84.13K
Capitalization166.25M
MetaVia
Price$0.65
Change+$0.02 (+3.17%)
Volume$33.35K
Capitalization15.66M
MCRB vs MTVA Comparison Chart in %
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. MTVA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Buy and MTVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (MCRB: $18.99 vs. MTVA: $0.65)
Brand notoriety: MCRB and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 59% vs. MTVA: 31%
Market capitalization -- MCRB: $166.25M vs. MTVA: $15.66M
MCRB [@Biotechnology] is valued at $166.25M. MTVA’s [@Biotechnology] market capitalization is $15.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 1 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, MCRB is a better buy in the long-term than MTVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 5 TA indicator(s) are bullish while MTVA’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 5 bullish, 4 bearish.
  • MTVA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both MCRB and MTVA are a good buy in the short-term.

Price Growth

MCRB (@Biotechnology) experienced а +3.66% price change this week, while MTVA (@Biotechnology) price change was +1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($166M) has a higher market cap than MTVA($15.7M). MCRB YTD gains are higher at: 14.260 vs. MTVA (-68.128). MTVA has higher annual earnings (EBITDA): -20.01M vs. MCRB (-49.22M). MCRB has more cash in the bank: 45.4M vs. MTVA (17.6M). MTVA has less debt than MCRB: MTVA (98K) vs MCRB (87.4M). MCRB (0) and MTVA (0) have equivalent revenues.
MCRBMTVAMCRB / MTVA
Capitalization166M15.7M1,057%
EBITDA-49.22M-20.01M246%
Gain YTD14.260-68.128-21%
P/E RatioN/AN/A-
Revenue00-
Total Cash45.4M17.6M258%
Total Debt87.4M98K89,184%
FUNDAMENTALS RATINGS
MCRB vs MTVA: Fundamental Ratings
MCRB
MTVA
OUTLOOK RATING
1..100
241
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3589
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (21) in the null industry is in the same range as MCRB (45) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MTVA's SMR Rating (100) in the null industry is in the same range as MCRB (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MCRB’s over the last 12 months.

MCRB's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for MTVA (89) in the null industry. This means that MCRB’s stock grew somewhat faster than MTVA’s over the last 12 months.

MCRB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MTVA (100) in the null industry. This means that MCRB’s stock grew similarly to MTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBMTVA
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 24 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPUS0.560.02
+4.06%
Hyperscale Data Inc
GSAT28.740.54
+1.91%
Globalstar Inc
EXR142.320.75
+0.53%
Extra Space Storage
JYNT10.67-0.03
-0.28%
Joint Corp (The)
EXOD26.16-1.09
-4.00%
Exodus Movement Inc

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+0.58%
ORMP - MCRB
42%
Loosely correlated
-0.45%
AXON - MCRB
38%
Loosely correlated
+1.59%
AMRN - MCRB
36%
Loosely correlated
-0.42%
MTVA - MCRB
35%
Loosely correlated
+2.05%
ARRY - MCRB
34%
Loosely correlated
+0.89%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with MCRB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then MCRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+2.05%
MCRB - MTVA
35%
Loosely correlated
+0.58%
PMVP - MTVA
35%
Loosely correlated
+1.41%
KPRX - MTVA
30%
Poorly correlated
-2.80%
IMTX - MTVA
28%
Poorly correlated
-2.22%
ANNX - MTVA
28%
Poorly correlated
+0.47%
More